Cerus Corp (CERS) stock
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3027% below fair value
$1.94+0.04 (+2.11%)
Close on Nov 18, 2026Market cap $390.96MP/E –Yield –
Cerus net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cerus's net income for the twelve months ending Sep 30, 2026 was -$7.31M. For fiscal 2025 it was -$15.63M. The highest annual figure on record is -$15.63M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.63M | – |
| FY2024 | Dec 31, 2024 | -$20.92M | – |
| FY2023 | Dec 31, 2023 | -$37.49M | – |
| FY2022 | Dec 31, 2022 | -$42.78M | – |
| FY2021 | Dec 31, 2021 | -$54.37M | – |
| FY2020 | Dec 31, 2020 | -$59.86M | – |
| FY2019 | Dec 31, 2019 | -$71.24M | – |
| FY2018 | Dec 31, 2018 | -$57.56M | – |
| FY2017 | Dec 31, 2017 | -$60.59M | – |
| FY2016 | Dec 31, 2016 | -$62.91M | – |
| FY2015 | Dec 31, 2015 | -$55.87M | – |
| FY2014 | Dec 31, 2014 | -$38.76M | – |
| FY2013 | Dec 31, 2013 | -$43.34M | – |
| FY2012 | Dec 31, 2012 | -$15.92M | – |
| FY2011 | Dec 31, 2011 | -$16.98M | – |
| FY2010 | Dec 31, 2010 | -$16.91M | – |
| FY2009 | Dec 31, 2009 | -$24.14M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$550.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$2.94M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.64M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.72M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.93M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.69M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.33M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.27M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.62M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.62M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.48M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.39M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.28M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.12M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.44M | – |
| Q2 FY2021 | Jun 30, 2021 | -$15.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$17.46M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.38M | – |
| Q3 FY2020 | Sep 30, 2020 | -$14.14M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.87M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.47M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.92M | – |
| Q3 FY2019 | Sep 30, 2019 | -$17.97M | – |
| Q2 FY2019 | Jun 30, 2019 | -$17.56M | – |
| Q1 FY2019 | Mar 31, 2019 | -$18.79M | – |
| Q4 FY2018 | Dec 31, 2018 | -$16.21M | – |
| Q3 FY2018 | Sep 30, 2018 | -$14.19M | – |
| Q2 FY2018 | Jun 30, 2018 | -$13.28M | – |
| Q1 FY2018 | Mar 31, 2018 | -$13.89M | – |
| Q4 FY2017 | Dec 31, 2017 | -$11.49M | – |
| Q3 FY2017 | Sep 30, 2017 | -$13.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$17.08M | – |
| Q1 FY2017 | Mar 31, 2017 | -$18.60M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.50M | – |
See a number that looks wrong?